Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,033Revenue $M75.4Net Margin (%)-100.2Z-Score5.3
Enterprise Value $M972EPS $-0.5Operating Margin %-94.8F-Score5
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-100.1Higher ROA y-yN
Price/Book14.410-y EBITDA Growth Rate %-13.1Quick Ratio3.0Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %16.4Current Ratio3.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-99.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-408.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M160ROI % (ttm)-84.5Gross Margin Increase y-yY

Gurus Latest Trades with AVNR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

AVNR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AVNR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Katkin KeithPresident and CEO 2014-08-01Sell9,670$5.2616.54 view
Siffert Joao MDSVP, R&D 2014-05-28Sell13,547$5.1818.34 view
Katkin KeithPresident and CEO 2014-05-28Sell442,212$5.0122.36 view
OCAMPO CHRISTINEVice President, Finance 2014-05-16Sell37,496$5.0521.39 view
Katkin KeithPresident and CEO 2013-12-18Sell29,515$2.67129.59 view
OCAMPO CHRISTINEVice President, Finance 2013-12-18Sell2,450$2.63133.08 view
Siffert Joao MDSVP, R&D 2013-12-18Sell5,970$2.63133.08 view
PALEKAR ROHANSVP & Chief Commercial Officer 2013-12-17Buy10,000$2.8118.93 view
PALEKAR ROHANSVP & Chief Commercial Officer 2013-11-04Buy10,000$4.1946.3 view
Katkin KeithPresident and CEO 2013-11-01Sell4,385$4.1448.07 view

Press Releases about AVNR :

    Quarterly/Annual Reports about AVNR:

    News about AVNR:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Danaher Corporation, Orbitz Worldwide Inc., 3D Systems Corporation and A May 20 2013 
    Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 
    Options V: Short-Term Strategy – Earning Money on Volatility Oct 19 2011 
    Avanir Pharmaceuticals Reports Operating Results (10-Q) Feb 07 2011 
    Avanir Pharmaceuticals Reports Operating Results (10-K) Dec 08 2010 
    Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 195,300 Shares Dec 03 2010 
    Weekly CEO Sells Highlights: MAC, GNET, ASIA, and AVNR Sep 05 2010 
    Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 102,874 Shares Sep 02 2010 
    Avanir Pharmaceuticals Reports Operating Results (10-Q) Aug 05 2010 
    Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 105,906 Shares May 04 2010 

    More From Our Partners
    Will Avanir (AVNR) Continue to Surge Higher? - Tale of the Tape Aug 26 2014 - ZACKS

    More From Other Websites
    Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive... Aug 26 2014
    Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive... Aug 26 2014
    Will Avanir (AVNR) Continue to Surge Higher? Aug 26 2014
    AVANIR PHARMACEUTICALS, INC. Financials Aug 15 2014
    AVANIR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 07 2014
    Avanir's Q3 Loss in Line, Revenues Up on High Nuedexta Demand Aug 06 2014
    Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update Aug 05 2014
    Avanir Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Aug 05 2014
    AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2014
    Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update Aug 05 2014
    Avanir Pharmaceuticals to Participate in Two Conferences in August Aug 05 2014
    Avanir Pharmaceuticals to Participate in Two Conferences in August Aug 05 2014
    Q3 2014 Avanir Pharmaceuticals Earnings Release - After Market Close Aug 05 2014
    Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference... Jul 28 2014
    Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference... Jul 28 2014
    Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of... Jul 21 2014
    Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of... Jul 21 2014
    Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study Jul 16 2014
    Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study Jul 16 2014
    3 Biotech Stocks Under $10 to Trade for Breakouts Jul 11 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK